Effect of instillation of ultrafine carbon black into the lower airway of mice on mortality from Streptococcus pneumoniae

A. Tellabati, P. Andrew, J. Grigg (Leicester, London, United Kingdom)

Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Session: Mechanisms of respiratory infections: interaction between the pathogen and the host
Session type: Thematic Poster Session
Number: 2298
Disease area: Respiratory infections

Congress or journal article abstract

Abstract

Introduction: In the developing world, exposure to indoor air pollution from biomass smoke is associated with increased vulnerability to pneumococcal pneumonia. Since carbon-containing ultrafine particles mediate many of the health effects, we hypothesised that instillation of aggregates of carbon black nanoparticles into the lower airway of mice would enhance mortality from pneumococcal pneumonia.
Methods: Female MF1 mice were used for the study. On day 1, either 50 µl of phosphate buffered saline (PBS), or 500 µg of ultrafine carbon black (UFCB) in 50µl of PBS was instilled into the nasopharynx of anaesthetised mice. Instillation was repeated on day 4. 1 x 106 S. pneumoniae inoculum in 50 µl of PBS was instilled into the nasopharynx of PBS and UFCB-exposed mice on day 7, and mortality was assessed over 72 hrs.These data were replicated in a separate challenge.
Result: All PBS-exposed mice died from pneumococcal infection within 48 hours. In contrast, 50% of the mice in UFCB group survived at 72 hours (difference between groups by Kaplan Mier, p=0.0017). Mice that survived upto 3 days were all clinically healthy.
Discussion: These data do not support our hypothesis that exposure to UFCB increases vulnerability to pneumococcal pneumonia. Indeed, a paradoxical ²protective² effect was found. We speculate that UFCB upregulates lung innate immunity, and that the adverse health effects of biomass smoke may be mediated by compounds absorbed onto carbon particles – or other gaseous components.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Tellabati, P. Andrew, J. Grigg (Leicester, London, United Kingdom). Effect of instillation of ultrafine carbon black into the lower airway of mice on mortality from Streptococcus pneumoniae. Eur Respir J 2008; 32: Suppl. 52, 2298

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between the inoculum dose of Streptococcus pneumoniae and pneumonia onset in a rabbit model
Source: Eur Respir J 2005; 25: 693-700
Year: 2005



Effects of inhalation of particulate matter and sulphur dioxide on markers of upper and lower airway inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 617s
Year: 2006

Inflammatory toxicity in rats following intratracheal instillation of ultrafine carbon black with and without benzo[a]pyrene and/or iron sulphate
Source: Eur Respir J 2004; 24: Suppl. 48, 606s
Year: 2004

Extrapulmonary effects of inhaled ultrafine carbon particles in mice
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008

Influence of environmental conditions and pollution on the incidence of Streptococcus pneumoniae infections
Source: ERJ Open Res, 3 (4) 00014-2017; 10.1183/23120541.00014-2017
Year: 2017



Intranasal administration of lipopolysaccharide (LPS) during a chronic pulmonary infection with streptococcus pneumoniae resulted in a synergistic effect on neutrophil influx in mice
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Vasculotide stabilizes pulmonary barrier function in Streptococcus pneumoniae infected and mechanically ventilated mice
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019

The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 640s
Year: 2004

Silica nanoparticles enhance mortality and increase lung permeability during Pseudomonas aeruginosa infection
Source: Lung Science Conference 2015
Year: 2015




Exposure to particulate matter increases pyocyanin production in Pseudomonas aeruginosa
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017

Respiratory Chlamydophyla pneumoniae resides primarily in the lower airway
Source: Eur Respir J 2011; 38: 995
Year: 2011


Respiratory Chlamydophyla pneumoniae resides primarily in the lower airway
Source: Eur Respir J 2011; 38: 994-995
Year: 2011


Inhaled corticosteroids and risk of oropharyngeal colonization by streptococcus pneumoniae in children with asthma
Source: Annual Congress 2012 - Treating childhood asthma
Year: 2012

Changes in susceptibility to antibiotics staphylococcus aureus under effect of dissolved ozone
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009

Particulate matter (PM10) alters the virulence of pseudomonas aeruginosa strain PA01
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013

Fate of inhaled ultrafine carbon particles after one week; human exposure using a novel aerosol with 111indium
Source: Annual Congress 2012 - Air pollution: from the particles in town to the pollutants in the countryside
Year: 2012

Chronic effects of nasally instilled diesel exhaust particulates on the respiratory tract of mice
Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease
Year: 2010


Haemophilus influenzae persists in biofilm communities in a smoke-exposed ferret model of COPD
Source: ERJ Open Res, 6 (3) 00200-2020; 10.1183/23120541.00200-2020
Year: 2020



Inhaled corticosteroid use and its association with Pseudomonas aeruginosa infection in COPD
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021